Breaking News Instant updates and real-time market news.

AKCA

Akcea Therapeutics

$23.22

0.22 (0.96%)

16:17
02/15/18
02/15
16:17
02/15/18
16:17

Akcea Therapeutics announces FDA committee meeting to review volanesorsen

Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, announced that the Division of Metabolism and Endocrinology Products of the FDA will hold an advisory committee meeting to review data supporting the new drug application, or NDA, for volanesorsen. The meeting is tentatively scheduled for May 10. Volanesorsen is an investigational therapy for the treatment of a rare lipid disorder called familial chylomicronemia syndrome, which is characterized by the buildup of fats in the body due to a deficiency in the enzyme lipoprotein lipase.

  • 26

    Apr

AKCA Akcea Therapeutics
$23.22

0.22 (0.96%)

08/08/17
08/08/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN), Alphabet (GOOG, GOOGL), and Facebook (FB) were reinstated with a Buy at Mizuho, while eBay (EBAY) and Twitter (TWTR) were reinstated with an Underperform. 2. Broadridge (BR) initiated with a Neutral at DA Davidson. 3. Brighthouse Financial (BHF) initiated with an Overweight at Barclays. 4. Akcea Therapeutics (AKCA) WAS initiated with an Outperform at BMO Capital and Cowen, an Outperform at Wells Fargo, as well as a Buy at Stifel. 5. Lockheed Martin (LMT) and Raytheon (RTN) were initiated with an Overweight at Morgan Stanley, while Northrop Grumman (NOC) was initiated with an Equal Weight, and General Dynamics (GD) was initiated with an Underweight at the firm. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/17
BMOC
08/08/17
INITIATION
BMOC
Outperform
Akcea Therapeutics initiated with an Outperform at BMO Capital
BMO Capital analyst Do Kim started coverage of Akcea with a $25 price target and an Outperform rating. The analyst says the company provides "a commercial-ready, rare disease drug opportunity, with a validating partnership lead candidate" at a "small-cap valuation." Kim predicts that the company's volanesorsen, a triglyceride-lowering drug being developed for two rare, severe genetic disorders, Familial Chylomicronemia Syndrome and Familial Partial Lipodystrophy, will be approved as a treatment for FCS in 2H18 and generate worldwide peak sales of $800M.
08/08/17
WELS
08/08/17
INITIATION
Target $27
WELS
Outperform
Akcea Therapeutics initiated with an Outperform at Wells Fargo
Wells Fargo analyst Jim Birchenough started Akcea Therapeutics with an Outperform rating and $27 price target. The analyst sees potential blockbuster opportunity for the company's lead antisense oligonucleotide therapeutic volanesorsen in patients with familial chylomicronemia syndrome and other severe lipid disorders.
08/08/17
COWN
08/08/17
INITIATION
COWN
Outperform
Akcea Therapeutics initiated with an Outperform at Cowen
Cowen analyst Eric Schmidt initiated Akcea Therapeutics with an Outperform saying lead candidate volanesorsen, a triglyceride-lowering drug being developed for two rare, severe genetic disorders, Familial Chylomicronemia Syndrome and Familial Partial Lipodystrophy, has demonstrated unparalleled potency at reducing serum triglycerides in Phase III trials in patients with severe hypertriglyceridemia. The analyst sees $500M+ in peak sales potential for volanesorsen in Familial Chylomicronemia Syndrome and expects shares to move higher as investors gain conviction in this commercial outlook and the rest of the clinical pipeline.

TODAY'S FREE FLY STORIES

ALTM

Altus Midstream Company

$8.72

-0.71 (-7.53%)

09:30
12/17/18
12/17
09:30
12/17/18
09:30
Hot Stocks
Breaking Hot Stocks news story on Altus Midstream Company »

Altus Midstream Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$365.69

-11.17 (-2.96%)

, AAPL

Apple

$165.48

-5.45 (-3.19%)

09:26
12/17/18
12/17
09:26
12/17/18
09:26
Periodicals
Designer Andrew Kim departs Tesla to join Apple, The Verge reports »

Tesla (TSLA) senior…

TSLA

Tesla

$365.69

-11.17 (-2.96%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTSX

Point 360

$0.00

(0.00%)

09:25
12/17/18
12/17
09:25
12/17/18
09:25
Hot Stocks
Court approves Point 360 second amended disclosure statement »

Point.360 announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.49

0.1 (0.41%)

09:24
12/17/18
12/17
09:24
12/17/18
09:24
Hot Stocks
Bank of America reports November card write-offs 2.68% vs. 2.43% last month »

Reports November 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

IBTX

Independent Bank

$47.72

-1.6 (-3.24%)

, GBNK

Guaranty Bancorp

$21.44

-0.65 (-2.94%)

09:24
12/17/18
12/17
09:24
12/17/18
09:24
Hot Stocks
Independent Bank receives regulatory approval for Guaranty Bancorp merger »

Independent Bank (IBTX)…

IBTX

Independent Bank

$47.72

-1.6 (-3.24%)

GBNK

Guaranty Bancorp

$21.44

-0.65 (-2.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

09:22
12/17/18
12/17
09:22
12/17/18
09:22
Conference/Events
UBS retail analyst to hold an analyst/industry conference call »

Retail Analyst Sole…

MDT

Medtronic

$93.78

-1.7 (-1.78%)

09:22
12/17/18
12/17
09:22
12/17/18
09:22
Hot Stocks
Medtronic announces FDA approval of InterStim programmer »

Medtronic announced FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$24.78

0.8 (3.34%)

09:21
12/17/18
12/17
09:21
12/17/18
09:21
Recommendations
Smartsheet analyst commentary  »

William Blair remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

SWGAY

Swatch Group

$0.00

(0.00%)

09:20
12/17/18
12/17
09:20
12/17/18
09:20
Downgrade
Swatch Group rating change  »

Swatch Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:20
12/17/18
12/17
09:20
12/17/18
09:20
General news
U.S. equities continue to backtrack »

U.S. equities continue to…

GNUS

Genius Brands

$2.38

(0.00%)

09:19
12/17/18
12/17
09:19
12/17/18
09:19
Hot Stocks
Genius Brands licenses rights to Gershwin Entertainment for Rainbow Rangers live »

Genius Brands new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEN

Zendesk

$59.93

-1.26 (-2.06%)

09:19
12/17/18
12/17
09:19
12/17/18
09:19
Recommendations
Zendesk analyst commentary  »

Zendesk shares can offer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

NTRP

Neurotrope

$4.08

-0.18 (-4.23%)

09:18
12/17/18
12/17
09:18
12/17/18
09:18
Syndicate
Neurotrope announces $22.5M registered direct offering »

Neurotrope announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
12/17/18
12/17
09:18
12/17/18
09:18
Options
Overnight activity included 611 trades in SPX and 21 trades in VIX »

611 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:17
12/17/18
12/17
09:17
12/17/18
09:17
Conference/Events
UBS U.S. Internet analyst to hold an analyst/industry conference call »

U.S. Internet Analyst…

CUTR

Cutera

$16.49

-0.6 (-3.51%)

09:16
12/17/18
12/17
09:16
12/17/18
09:16
Hot Stocks
Cutera announces FDA approval of new indication for enlighten laser platform »

Cutera announced the FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASH

Ashland

$72.92

-1.52 (-2.04%)

09:16
12/17/18
12/17
09:16
12/17/18
09:16
Initiation
Ashland initiated  »

Ashland initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$136.40

-2.39 (-1.72%)

09:16
12/17/18
12/17
09:16
12/17/18
09:16
Hot Stocks
Honeywell announces new e-commerce platform 'GoDirect Trade' »

Honeywell is bringing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

GS

Goldman Sachs

$172.80

-3.07 (-1.75%)

, EVFM

Evofem

$3.50

-0.28 (-7.41%)

09:16
12/17/18
12/17
09:16
12/17/18
09:16
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Evofem (EVFM), up…

GS

Goldman Sachs

$172.80

-3.07 (-1.75%)

EVFM

Evofem

$3.50

-0.28 (-7.41%)

AXON

Axovant Sciences

$1.01

-0.12 (-10.62%)

BKS

Barnes & Noble

$6.49

-0.17 (-2.55%)

JACK

Jack in the Box

$80.22

-2.27 (-2.75%)

WFT

Weatherford

$0.43

-0.0258 (-5.61%)

BBY

Best Buy

$55.37

-0.56 (-1.00%)

THC

Tenet

$21.24

-2.25 (-9.58%)

CNC

Centene

$127.55

-5.3 (-3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 05

    Feb

  • 19

    Feb

PSTI

Pluristem

$0.85

-0.0607 (-6.67%)

09:15
12/17/18
12/17
09:15
12/17/18
09:15
Hot Stocks
Pluristem provides recap of KOL meeting on PAD »

Pluristem provided a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:15
12/17/18
12/17
09:15
12/17/18
09:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

MAXR

Maxar Technologies

$12.47

-0.39 (-3.03%)

09:14
12/17/18
12/17
09:14
12/17/18
09:14
Hot Stocks
Maxar's MDA, Orbital Insight expand SAR satellite imagery agreement »

MDA, a Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$112.85

-2.54 (-2.20%)

09:13
12/17/18
12/17
09:13
12/17/18
09:13
Hot Stocks
ResMed subsidiary Brightree acquires Apacheta, terms not disclsoed »

Brightree announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WWE

WWE

$72.61

-1.06 (-1.44%)

, SKYAY

Sky

$0.00

(0.00%)

09:13
12/17/18
12/17
09:13
12/17/18
09:13
Hot Stocks
WWE, Sky extend partnership in New Zealand »

WWE (WWE) and SKY (SKYAY)…

WWE

WWE

$72.61

-1.06 (-1.44%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

OSTK

Overstock.com

$17.20

-0.77 (-4.28%)

09:11
12/17/18
12/17
09:11
12/17/18
09:11
Hot Stocks
Overstock.com, tZERO to develop commodity contract token for GSR Capital »

Overstock.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.